Our study reveals that the interplay between osteoblasts and AML cells through the mTORC1/IL-6-IL-6R/JAK/STAT3 axis contributes to the feedforward loop of AML progression, suggesting that modifying this axis could offer an effective strategy for disease management and relapse prevention. Here, IL6R is linked to acute myeloid leukemia.